Compare DexCom, Inc. (DXCM) vs Palo Alto Networks Inc (PANW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Palo Alto Networks Inc — how do they compare? DexCom, Inc. trades at $77.54 (market cap $28.06B), while Palo Alto Networks Inc trades at $353.07 (market cap $288.53B). The key difference: Palo Alto Networks Inc is far larger — about 10.3× DexCom, Inc.'s market cap, and Palo Alto Networks Inc is trading nearer its 52-week high, DexCom, Inc. nearer its low. Which is the better fit depends on your goals.
| DXCM | PANW | |
|---|---|---|
Market Cap | $28.06B | $288.53B |
Sector | Health | Technology |
52-Week High | $89.53 | $357.53 |
52-Week Low | $54.84 | $141.67 |
Enterprise Value | $27.03B | $287.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
Palo Alto Networks (PANW) trades at $354.65, up 0.5% today, with a bullish technical outlook supported by moving averages and recent earnings beats. The company shows strong revenue growth, reaching $9.22B in 2025, though valuation ratios like P/E of 307.84 remain elevated. Positive sentiment is driven by AI cybersecurity demand, with news highlighting sector rallies and platform expansion strategies.
Outlook: Growth prospects are solid amid AI-driven security spending, but high valuations and integration costs pose risks. Analyst consensus is bullish with a $339.56 price target, though competition and margin pressures require monitoring for sustained shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Palo Alto Networks Inc
Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.
Read more on PANW →
